KLF15 and proximal spinal muscular atrophy: Specifically, we observed a significant downregulation of Klf15 expression in presymptomatic SMA mice and found that its neonatal upregulation via pharmacological (prednisolone) or transgenic (muscle-specific Klf15 overexpression) interventions significantly improved several disease phenotypes in SMA mice [18].